Finance

Lists
1ZTS:BIT
Zoetis Inc
€ 61.60
-0.93%
(-0.58) 1D
10-р сарын 2, 17:26:00 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1ZTS...
Open
€ 61.60
High
€ 61.60
Low
€ 61.60
Mkt. cap
30.91 тэрбум
Avg. vol.
384.00
Volume
8.00
52-wk high
€ 130.06
52-wk low
€ 61.04
No. of employees
14 мян
Open
€ 61.60
High
€ 61.60
Low
€ 61.60
Mkt. cap
30.91 тэрбум
Avg. vol.
384.00
Volume
8.00
52-wk high
€ 130.06
52-wk low
€ 61.04
No. of employees
14 мян
News stories
From web sources and news partners
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries. In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5 мян
Founded1952
HeadquartersParsippany-Troy Hills, Нью Жерси, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Websitezoetis.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.40 тэрбум
2.39 тэрбум
2.26 тэрбум
2.47 тэрбум
Cost of goods sold
682.00 сая
711.00 сая
640.00 сая
670.00 сая
Cost of revenue
682.00 сая
711.00 сая
640.00 сая
670.00 сая
Research and development expenses
170.00 сая
199.00 сая
180.00 сая
173.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
572.00 сая
618.00 сая
584.00 сая
589.00 сая
Operating expense
774.00 сая
848.00 сая
795.00 сая
793.00 сая
Total operating expenses
1.46 тэрбум
1.56 тэрбум
1.44 тэрбум
1.46 тэрбум
Operating income
944.00 сая
828.00 сая
827.00 сая
1.00 тэрбум
Other non operating income
-
-6.00 сая
-1.00 сая
-2.00 сая
EBT including unusual items
887.00 сая
761.00 сая
758.00 сая
866.00 сая
EBT excluding unusual items
899.00 сая
780.00 сая
779.00 сая
948.00 сая
Income tax expense
166.00 сая
158.00 сая
157.00 сая
175.00 сая
Effective tax rate
18.71%
20.76%
20.71%
20.21%
Other operating expenses
-
-
-
-
Net income
721.00 сая
603.00 сая
601.00 сая
691.00 сая
Net profit margin
30.04%
25.26%
26.57%
28.00%
Earnings per share
1.70
1.48
1.53
1.87
Interest and investment income
26.00 сая
25.00 сая
21.00 сая
16.00 сая
Interest expense
-58.00 сая
-57.00 сая
-62.00 сая
-61.00 сая
Net interest expenses
-32.00 сая
-32.00 сая
-41.00 сая
-45.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.07 тэрбум
903.00 сая
946.00 сая
1.12 тэрбум
Gain or loss from assets sale
-
-
-6.00 сая
-1.00 сая
AI content may include mistakes. Learn more
Google аппс